Full Breakdown
Recent Funding Rounds Highlight Growth in Indian Health-Tech Startups
9/6/2025, 11:27:02 AM
Overview of Recent Funding Events
Several Indian health-tech startups have recently secured significant funding to enhance their operations and expand their market presence. Notable among these are RxMen, Dectrocel, and FlexifyMe, each focusing on innovative solutions to address various health challenges.
RxMen Secures INR 5 Crore for Men's Health
RxMen, a men's health tech startup based in Delhi, has raised INR 5 crore in a seed funding round led by Inflection Point Ventures. Other participants included SPA Family Ventures, Ankit Goel, and Seven Square Ventures, along with a grant from Prosus Group. Founded in 2023 by Shailja Mittal, RxMen aims to establish co-branded clinics and introduce products under its label, targeting areas such as sexual health and hormonal balance. The startup reported a monthly recurring revenue of USD 70,000 as of August 2025 and aims to achieve positive EBITDA by October 2025.
Dectrocel Raises INR 4 Crore for AI-Driven Diagnostics
Dectrocel, a Lucknow-based health-tech startup, has raised INR 4 crore in funding led by IAN BioAngels, with contributions from PadUp Ventures and Vinners. Founded in 2020 by Ankit Shukla, Saumya Shukla, and Nikhil Mishra, Dectrocel focuses on AI solutions for respiratory and hepato-pancreatico-biliary diseases. Its flagship product, DecXpert, is an AI-based diagnostic tool approved for clinical use in India, capable of interpreting chest X-rays and CT scans with 98% accuracy. The funding will be utilized to scale operations and expand into global markets.
FlexifyMe Secures INR 20 Crore for Expansion
FlexifyMe, a Pune-based startup specializing in AI-driven posture and motion analysis, has raised INR 20 crore in a pre-Series A funding round led by IvyCap Ventures. The company plans to use the funds to enhance its hybrid expansion strategy, which includes launching advanced posture analysis labs and strengthening clinical research collaborations. Founded in 2021 by Manjeet Singh and Amit Bhayani, FlexifyMe aims to shift healthcare from symptom-based approaches to data-driven interventions, thereby improving long-term outcomes for patients.
Criticism & Opposition
While these funding rounds signify growth in the health-tech sector, critics argue that the rapid expansion of startups may lead to oversaturation in the market. Competitors such as Man Matters and Bold Care for RxMen, and PhableCare and Portl for FlexifyMe, highlight the competitive landscape that these startups must navigate.
Official Statements & Responses
Dr. Nikhil Agarwal, Managing Director of the Foundation for Innovation and Technology Transfer at IIT Delhi, emphasized the importance of initiatives like the India-UAE Startup Exchange in fostering international collaboration. He noted that such programs provide startups with essential support for scaling their operations globally.
Verbatim Quotes
- “We’re thrilled to take our vision further and make advanced diagnostics available to everyone.” — Ankit Shukla, Co-Founder, Dectrocel
- “This funding allows us to scale these capabilities so millions can avoid unnecessary surgeries, return to the activities they love, and regain meaningful quality of life," said Manjeet Singh, co-founder, FlexifyMe.” — Manjeet Singh, Co-Founder, FlexifyMe
What's Next
As these startups continue to grow, they are expected to explore partnerships with hospitals and expand their offerings in both domestic and international markets. The health-tech sector in India is poised for further innovation, driven by the increasing demand for accessible and efficient healthcare solutions.
